A detailed history of Science & Technology Partners, L.P. transactions in Glaukos Corp stock. As of the latest transaction made, Science & Technology Partners, L.P. holds 51,750 shares of GKOS stock, worth $7.92 Million. This represents 2.36% of its overall portfolio holdings.

Number of Shares
51,750
Holding current value
$7.92 Million
% of portfolio
2.36%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$126.42 - $152.67 $6.54 Million - $7.9 Million
51,750 New
51,750 $7.76 Billion

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.28B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Science & Technology Partners, L.P. Portfolio

Follow Science & Technology Partners, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Science & Technology Partners, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Science & Technology Partners, L.P. with notifications on news.